About N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide
N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide (PubChem CID 109103878) has the molecular formula C15H16N4O4
and a molecular weight of 316.32 g/mol. Its IUPAC name is N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide.
Analyze N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide?
The IUPAC name of N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide (CID 109103878) is N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide.
What is the SMILES notation for N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide?
The canonical SMILES for N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide is Cc1cc(NC(=O)c2cncc(C(=O)N3CCOCC3)c2)no1.
What is the InChIKey of N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide?
The InChIKey is LWWOPIPKQDYXTR-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H16N4O4/c1-10-6-13(18-23-10)17-14(20)11-7-12(9-16-8-11)15(21)19-2-4-22-5-3-19/h6-9H,2-5H2,1H3,(H,17,18,20).
What are the key properties of N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide?
N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide has a molecular weight of 316.32 g/mol, XLogP of 1.10, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-methyl-1,2-oxazol-3-yl)-5-(morpholine-4-carbonyl)pyridine-3-carboxamide is sourced from PubChem (CID 109103878), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).